Skip to main content

PCRX · PharmaCorp Rx Inc. · Financials

0.3950 CAD -0.0100 (-2.47%) At close · Nov 6 Intraday price with Plus
Market Cap
77.81M CAD
Shares
196.98M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
20.89M +260.6%
FY2025 Revenue FY2024–FY2025
Net Income
-1.48M -46.3%
FY2025 Net Income FY2024–FY2025
Gross Margin
39.72% +2pp
FY2025 Gross Margin FY2024–FY2025
Operating Margin
-6.2% +21.5pp
FY2025 Operating Margin FY2024–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024
CAD 20.89M 5.79M
CAD 8.3M 2.18M
CAD -1.29M -1.6M
CAD -835.8K -1.16M
CAD -1.48M -1.01M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.